Federal Rescheduling Hearing Puts Cannabis Operators and Compliance on Notice
The DEA opened formal proceedings Monday on a proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act - the most consequential federal drug policy proceeding in
DOJ Moves to Reschedule Cannabis, Reshaping Federal Policy for U.S. Operators
The U.S. Department of Justice announced Thursday it would immediately ease restrictions on state-regulated medical marijuana products and fast-track proceedings to reclassify cannabis more broadly -
Trump Executive Order Pushes Cannabis Rescheduling Forward, Threatening 280E's Grip
On December 18, 2025, President Donald J. Trump signed an Executive Order directing the Attorney General to finalize the rulemaking that would move marijuana from Schedule I to Schedule III of the
Federal Rescheduling of Medical Marijuana Opens the Door to International Trade
Effective April 28, 2026, the United States formally acknowledged medical marijuana as a legitimate controlled substance by moving it to Schedule III of the Controlled Substances Act - a shift that